Current management of non-alcoholic steatohepatitis - PubMed (original) (raw)

Review

. 2020 Feb;40 Suppl 1(Suppl 1):89-95.

doi: 10.1111/liv.14355.

Affiliations

Review

Current management of non-alcoholic steatohepatitis

Mark D Muthiah et al. Liver Int. 2020 Feb.

Abstract

Non-alcoholic steatohepatitis (NASH) is the most common cause of liver disease in Western populations, and its prevalence is increasing rapidly. It is part of a multisystem disease affecting other organs such as the kidneys, heart and blood vessels, and is closely associated with the components of the metabolic syndrome. Physicians managing patients with NASH should not only focus on the management of NASH, but also on associated comorbidities in individual patients. The approaches to treatment of NASH include either limiting energy surplus alone, or in combination with targeting of downstream pathways of inflammation and fibrosis. In this mini-review, we discuss the currently available treatment options for NASH, as well as those in late-stage clinical trials. We discuss the challenges of managing these patients with a limited number of approved therapies, as well as managing advanced-stage patients with NASH and cirrhosis. We also discuss the specific management of comorbidities in NASH patients, in particular diabetes, hypertension, dyslipidaemia and cardiovascular diseases. Finally, we present the screening protocols for both hepatocellular carcinoma and extrahepatic malignancies in these patients.

Keywords: management; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; treatment.

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234–238. - PubMed
    1. Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–1956. - PubMed
    1. Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829–846. - PubMed
    1. Siddiqui MS, Carbone S, Vincent R, et al. Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis. Clin Gastroenterol Hepatol. 2018. - PMC - PubMed
    1. Foster-Schubert KE, Alfano CM, Duggan CR, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring). 2012;20(8):1628–1638. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources